Estimating the future global dose demand for measles-rubella microarray patches

• Principais autores: Melissa Ko (Autor), Stefano Malvolti (Autor), Thomas Cherian (Autor), Carsten Mantel (Autor), Robin Biellik (Autor), Courtney Jarrahian (Autor), Marion Menozzi-Arnaud (Autor), Jean-Pierre Amorij (Autor), Hans Christiansen (Autor), Mark J. Papania (Autor), Martin I. Meltzer (Autor), Balcha Girma Masresha (Autor), Desiree Pastor (Autor), David N. Durrheim (Autor), Birgitte Giersing (Autor), Mateusz Hasso-Agopsowicz (Autor)
• Formato: Livro
• Publicado em: Frontiers Media S.A., 2023-01-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

BackgroundProgress toward measles and rubella (MR) elimination has stagnated as countries are unable to reach the required 95% vaccine coverage. Microarray patches (MAPs) are anticipated to offer significant programmatic advantages to needle and syringe (N/S) presentation and increase MR vaccination...